NCT03403283View on ClinicalTrials.gov

Dyslipidemia and Diabetic Retinopathy

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Diabetic RetinopathyDyslipidemia
Interventions
OTHER

15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy

OTHER

Healthy Controls 15 age matched control subjects

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT03403283 - Dyslipidemia and Diabetic Retinopathy | Biotech Hunter | Biotech Hunter